Actio Biosciences, Inc.
Taylor Ismaili is a Principal Scientist at Actio Biosciences, with extensive experience in in vitro biology and pharmacology. Taylor has previously held roles at Gossamer Bio, Synthorx Inc, and The Janssen Pharmaceutical Companies of Johnson & Johnson, where Taylor contributed significantly to various research and development projects. Taylor's educational background includes a Master of Science in Pharmacology and Toxicology from the University at Buffalo.
Actio Biosciences, Inc.
We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying biology in rare and common diseases — bringing meaningful medicines from one to many. With expertise in genetics, drug discovery and data sciences, we seek to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward exceptionally potent and precisely targeted therapeutics for patients.